Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schneider-Stock

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Der Pathologe|December 2, 2009
[Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy]A Agaimy, R Schneider-Stock
Behavior Genetics|September 1, 1995
Congenic AB mice: a novel means for studying the (molecular) genetics of aggressionR Schneider-Stock, J T Epplen
Human Mutation|January 1, 1997
New splicing mutation in exon 5-6 of the p53-tumor suppressor gene in a malignant schwannomaR Schneider-Stock, Y Oda, A Roessner
Molecular Carcinogenesis|February 1, 1997
Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft-tissue sarcomasR Schneider-Stock, K Radig, A Roessner
Der Pathologe|July 2, 2002
[Telomerase and new aspects for tumor biology]R Schneider-Stock, C Boltze, A Roessner
General & Diagnostic Pathology|May 1, 1996
Aggressive osteoblastoma with focal malignant transformation and development of pulmonary metastases. A case report with a review of literatureE Kunze, A Enderle, K Radig, et al.
Pathology, Research and Practice|August 24, 2001
Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literatureC Boltze, R Schneider-Stock, V Jäger, et al.
British Journal of Cancer|May 17, 2014
Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?L Heinzerling, G Schuler, A Hartmann, et al.
Pathology, Research and Practice|December 22, 1999
Telomerase activity in benign bone tumors and tumor-like lesionsA Kido, R Schneider-Stock, K Hauptmann, et al.
Pathology, Research and Practice|July 1, 1995
New aspects of cell biology in osteosarcomaE Grundmann, Y Ueda, R Schneider-Stock, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Der Pathologe|December 2, 2009
[Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy]A Agaimy, R Schneider-Stock
Behavior Genetics|September 1, 1995
Congenic AB mice: a novel means for studying the (molecular) genetics of aggressionR Schneider-Stock, J T Epplen
Human Mutation|January 1, 1997
New splicing mutation in exon 5-6 of the p53-tumor suppressor gene in a malignant schwannomaR Schneider-Stock, Y Oda, A Roessner
Molecular Carcinogenesis|February 1, 1997
Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft-tissue sarcomasR Schneider-Stock, K Radig, A Roessner
Der Pathologe|July 2, 2002
[Telomerase and new aspects for tumor biology]R Schneider-Stock, C Boltze, A Roessner
General & Diagnostic Pathology|May 1, 1996
Aggressive osteoblastoma with focal malignant transformation and development of pulmonary metastases. A case report with a review of literatureE Kunze, A Enderle, K Radig, et al.
Pathology, Research and Practice|August 24, 2001
Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literatureC Boltze, R Schneider-Stock, V Jäger, et al.
British Journal of Cancer|May 17, 2014
Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?L Heinzerling, G Schuler, A Hartmann, et al.
Pathology, Research and Practice|December 22, 1999
Telomerase activity in benign bone tumors and tumor-like lesionsA Kido, R Schneider-Stock, K Hauptmann, et al.
Pathology, Research and Practice|July 1, 1995
New aspects of cell biology in osteosarcomaE Grundmann, Y Ueda, R Schneider-Stock, et al.
Pageof 8